Liquidia (LQDA) Metrics: History & Chart

Liquidia Corporation(LQDA)

Medical - Pharmaceuticals · Morrisville, NC

$26.60-1.05 (-3.78%)

Delayed quote: Oct 6, 2026, 11:45 AM EDT

About Liquidia Corporation

Liquidia Corporation operates as a biopharmaceutical enterprise, concentrating on the development, production, and market introduction of various treatments aimed at fulfilling critical patient requirements throughout the United States. A key asset in its developmental portfolio is YUTREPIA, an innovative inhaled dry powder version of treprostinil, intended for managing pulmonary arterial hypertension. Beyond its pipeline, the company also distributes a generic treprostinil injection within the U.S. market. Founded in 2004, Liquidia Corporation's main office is located in Morrisville, North Carolina.

Morrisville, NC

216 employees

www.liquidia.com

Healthcare / Medical - Pharmaceuticals

Sector: Healthcare
Industry: Medical - Pharmaceuticals
CEO: Roger A. Jeffs

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	-62.48%
30D Total Return	-59.74%
YTD Total Return	-19.86%
1Y Total Return	+23.23%
3Y Total Return	+299.45%
5Y Total Return	+916.20%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-19.86%
2025	+193.28%
2024	-2.24%
2023	+88.85%
2022	+30.80%
2021	+65.08%
2020

CAGR TTM	+23.11%
CAGR 3Y	+58.65%
CAGR 5Y	+59.01%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	20.19
PE Ratio Avg TTM	352.62
PE Ratio Avg 3Y	352.62
Current VS TTM Avg	-94.27%
Current VS 3Y Avg	-94.27%
Current VS 5Y Avg	-94.27%

All Metrics

LQDA Valuation Metrics

LQDA Stock Price Metrics

LQDA Dividend Metrics

LQDA Growth Rate Metrics

LQDA Discounted Cash Flow Metrics

LQDA Returns By Period

LQDA Yearly Returns

LQDA Average Annual Returns By Period (CAGR)

LQDA Revenue Metrics

LQDA PE Ratio Metrics

LQDA PS Ratio Metrics

LQDA PB Ratio Metrics

LQDA Price to Free Cash Flow Ratio Metrics

LQDA Debt to Equity Ratio Metrics

LQDA PEG Ratio Metrics

LQDA FCF Yield

LQDA Earnings Yield

LQDA EBITDA Yield

LQDA OCF Yield

LQDA EV/EBIT Ratio Metrics

LQDA EV/EBITDA Ratio Metrics

LQDA EV/Assets Ratio Metrics

LQDA EV/Sales Ratio Metrics

LQDA Current Ratio Metrics

LQDA Quick Ratio Metrics

LQDA ROIC Metrics

LQDA Return on Assets Metrics

LQDA Return on Equity Metrics

LQDA Net Profit Margin Metrics

LQDA Gross Profit Margin Metrics

LQDA Tax Rate Metrics

PS Ratio	6.22
PS Ratio Avg TTM	29.95
PS Ratio Avg 3Y	55.08
Current VS TTM Avg	-79.23%
Current VS 3Y Avg	-88.71%
Current VS 5Y Avg	-84.50%

PB Ratio	14.36
PB Ratio Avg TTM	93.90
PB Ratio Avg 3Y	47.69
Current VS TTM Avg	-84.71%
Current VS 3Y Avg	-69.89%
Current VS 5Y Avg	+26.60%

PFCF Ratio	46.32
PFCF Ratio Avg TTM	116.25
PFCF Ratio Avg 3Y	116.25
Current VS TTM Avg	-60.16%
Current VS 3Y Avg	-60.16%
Current VS 5Y Avg	-60.16%

Debt/Equity Ratio	0.66
Debt/Equity Ratio Avg TTM	5.80
Debt/Equity Ratio Avg 3Y	1.15
Current VS TTM Avg	-88.61%
Current VS 3Y Avg	-42.49%
Current VS 5Y Avg	+16.98%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	2.16%
FCF Yield Avg TTM	0.86%
FCF Yield Avg 3Y	0.86%
Current VS TTM Avg	+151.78%
Current VS 3Y Avg	+151.78%
Current VS 5Y Avg	+151.78%

Earnings Yield	4.95%
Earnings Yield Avg TTM	0.84%
Earnings Yield Avg 3Y	0.84%
Current VS TTM Avg	+492.52%
Current VS 3Y Avg	+492.52%
Current VS 5Y Avg	+492.52%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	15.70
Ev/Ebit Ratio Avg TTM	116.99
Ev/Ebit Ratio Avg 3Y	116.99
Current VS TTM Avg	-86.58%
Current VS 3Y Avg	-86.58%
Current VS 5Y Avg	-86.58%

Ev/Ebitda Ratio	15.55
Ev/Ebitda Ratio Avg TTM	113.41
Ev/Ebitda Ratio Avg 3Y	113.41
Current VS TTM Avg	-86.29%
Current VS 3Y Avg	-86.29%
Current VS 5Y Avg	-86.29%

Ev/Assets Ratio	5.07
Ev/Assets Ratio Avg TTM	12.14
Ev/Assets Ratio Avg 3Y	7.41
Current VS TTM Avg	-58.22%
Current VS 3Y Avg	-31.53%
Current VS 5Y Avg	+1.74%

Ev/Sales Ratio	5.87
Ev/Sales Ratio Avg TTM	30.08
Ev/Sales Ratio Avg 3Y	46.03
Current VS TTM Avg	-80.49%
Current VS 3Y Avg	-87.25%
Current VS 5Y Avg	-82.42%

Current Ratio	2.31
Current Ratio Avg TTM	2.13
Current Ratio Avg 3Y	4.19
Current VS TTM Avg	+8.68%
Current VS 3Y Avg	-44.85%
Current VS 5Y Avg	-66.75%

Quick Ratio	2.12
Quick Ratio Avg TTM	1.99
Quick Ratio Avg 3Y	4.10
Current VS TTM Avg	+6.74%
Current VS 3Y Avg	-48.28%
Current VS 5Y Avg	-69.25%

ROIC	46.99%
ROIC Avg 3Y	(56.93%)
ROIC Avg 5Y	(46.80%)
Current VS 3Y Avg	+182.53%
Current VS 5Y Avg	+200.40%
Current VS 10Y Avg	+184.60%

ROA	26.56%
ROA Avg TTM	2.90%
ROA Avg 3Y	(9.34%)
Current VS TTM Avg	+816.67%
Current VS 3Y Avg	+384.42%
Current VS 5Y Avg	+329.78%

ROE	71.04%
ROE Avg TTM	(309.29%)
ROE Avg 3Y	(151.27%)
Current VS TTM Avg	+122.97%
Current VS 3Y Avg	+146.96%
Current VS 5Y Avg	+179.75%

Net Profit Margin	30.74%
Net Profit Margin Avg TTM	(75.58%)
Net Profit Margin Avg 3Y	(546.98%)
Current VS TTM Avg	+140.67%
Current VS 3Y Avg	+105.62%
Current VS 5Y Avg	+110.36%

Gross Profit Margin	92.48%
Gross Pft Margin Avg TTM	91.20%
Gross Pft Margin Avg 3Y	74.96%
Current VS TTM Avg	+1.40%
Current VS 3Y Avg	+23.38%
Current VS 5Y Avg	+17.63%

Tax Rate	8.54%
Tax Rate Avg 3Y	5.15%
Tax Rate Avg 5Y	5.15%
Current VS 3Y Avg	+65.87%
Current VS 5Y Avg	+65.87%
Current VS 10Y Avg	+121.16%